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Abstract
Introduction Monitoring of the cardiac output by continuous
arterial pulse contour (COPiCCOpulse) analysis is a clinically
validated procedure proved to be an alternative to the pulmonary
artery catheter thermodilution cardiac output (COPACtherm) in
cardiac surgical patients. There is ongoing debate, however, of
whether the COPiCCOpulse  is accurate after profound
hemodynamic changes. The aim of this study was therefore to
compare the COPiCCOpulse after cardiopulmonary bypass (CPB)
with a simultaneous measurement of the COPACtherm.
Methods After ethical approval and written informed consent,
data of 45 patients were analyzed during this prospective study.
During coronary artery bypass graft surgery, the aortic
transpulmonary thermodilution cardiac output (COPiCCOtherm)
and the COPACtherm were determined in all patients. Prior to
surgery, the COPiCCOpulse  was calibrated by triple
transpulmonary thermodilution measurement of the
COPiCCOtherm. After termination of CPB, the COPiCCOpulse was
documented. Both COPACtherm  and COPiCCOtherm  were also
simultaneously determined and documented.
Results Regression analysis between COPACtherm  and
COPiCCOtherm prior to CPB showed a correlation coefficient of
0.95 (P  < 0.001), and after CPB showed a correlation
coefficient of 0.82 (P < 0.001). Bland-Altman analysis showed
a mean bias and limits of agreement of 0.0 l/minute and -1.4 to
+1.4 l/minute prior to CPB and of 0.3 l/minute and -1.9 to +2.5
l/minute after CPB, respectively. Regression analysis of
COPiCCOpulse versus COPiCCOtherm and of COPiCCOpulse versus
COPACtherm after CPB showed a correlation coefficient of 0.67
(P < 0.001) and 0.63 (P < 0.001), respectively. Bland-Altman
analysis showed a mean bias and limits of agreement of -1.1 l/
minute and -1.9 to +4.1 l/minute versus -1.4 l/minute and -4.8 to
+2.0 l/minute, respectively.
Conclusion We observed an excellent correlation of
COPiCCOtherm and COPACtherm measurement prior to CPB. Pulse
contour analysis did not yield reliable results with acceptable
accuracy and limits of agreement under difficult conditions after
weaning from CPB in cardiac surgical patients. The pulse
contour analysis thus should be re-calibrated as soon as
possible, to prevent false therapeutic consequences.
Introduction
Measurement of cardiac output (CO) is widely used in cardiac
surgical patients. Over recent decades the main device for
determination of CO has been the pulmonary artery catheter
(PAC). The use of the PAC has been decreasing over recent
years in surgical and cardiac surgical patients, however, as the
benefit of guiding therapy with this device is unclear and the
use of the PAC might even lead to increased morbidity, as
shown in one large trial [1]. Other randomized studies indicate
no clear evidence of benefit or harm by managing critically ill
patients with a PAC [2,3].
Aortic transpulmonary thermodilution, a less invasive tech-
nique for determination of the CO, was therefore developed
and has gained increasing acceptance in clinical practice [4-
6]. Only an arterial line and a central venous line are needed to
CO = cardiac output; COPACtherm = pulmonary artery catheter thermodilution cardiac output; COPiCCOpulse = continuous arterial pulse contour analysis 
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determine the CO by this method [7]. Several investigators
found a good correlation between these two methods of CO
determination [4-6,8]. The device mostly used also offers con-
tinuous CO determination by arterial pulse contour analysis.
Stroke volume calculation and CO calculation by pulse con-
tour analysis was developed years ago and underwent several
methodological improvements of the algorithm [9,10]. Moni-
toring of the CO by continuous arterial pulse contour analysis
(COPiCCOpulse) is a widely used and clinically validated proce-
dure proved to be an alternative to the pulmonary artery cath-
eter thermodilution CO (COPACtherm) in cardiac surgical
patients [4,11]. Pulse contour monitoring demonstrated accu-
racy comparable with that of pulmonary artery thermodilution
using a clearly less invasive approach [5,11,12]. There is
ongoing debate, however, of whether the COPiCCOpulse is accu-
rate and reliable after profound changes of the hemodynamic
situation, such as after cardiopulmonary bypass (CPB) [4,13].
The aim of this study was therefore to compare the bias and
the limits of agreement (two standard deviations) of the COP-
iCCOpulse after CPB, with a simultaneous measurement of the
COPACtherm, as the gold standard of CO measurement.
Materials and methods
Patients
Following ethical committee approval and written informed
consent, 50 patients were considered eligible for this clinical
trial from February to November 2004. The inclusion criteria
were age >18 and <75 years, and elective coronary artery
bypass graft surgery. The exclusion criteria were withdrawal of
consent, valve pathologies, a left ventricular ejection fraction
<40% and symptomatic peripheral artery stenosis.
Perioperative management
Oral premedication was 0.1 mg/kg midazolam. In all patients a
femoral artery was cannulated with a 4-Fr cannula (Pulsiocath;
Pulsion Medical AG, Munich, Germany) prior to induction of
anesthesia. A central venous catheter and a pulmonary artery
catheter (Thermodilution Catheter; Arrow, Reading, PA, USA)
were inserted via the right internal jugular vein.
General anesthesia was induced with etomidate (0.2 mg/kg),
5 µg/kg fentanyl and 0.1 mg/kg pancuronium. Maintenance
was with infusion of 5–10 µg/kg per hour fentanyl, boluses of
Table 1
Patient characteristics
Mean Standard error 
of the mean
Age (years) 62 1
Height (m) 1.77 0.01
Body weight (kg) 91 2
Body mass index (kg/m2) 29.1 0.6
Number of grafts (n)3 0
Duration of anesthesia (minutes) 314 7
Duration of surgery (minutes) 201 6
Temperature prior to 
cardiopulmonary bypass (°C)
35.2 0.1
Temperature after cardiopulmonary 
bypass (°C)
36.1 0.1
Cardiopulmonary bypass time 
(minutes)
71 3
Aortic clamping time (minutes) 44 2
Table 2
Hemodynamic data
Mean Standard error 
of the mean
Heart rate prior to CPB (l/minute) 69 3
Heart rate after CPB (l/minute) 81* 2
Mean arterial pressure prior to CPB 
(mmHg)
70 2
Mean arterial pressure after CPB 
(mmHg)
73 2
Central venous pressure prior to 
CPB (mmHg)
91
Central venous pressure after CPB 
(mmHg)
11 1
Mean pulmonary arterial pressure 
prior to CPB (mmHg)
21 1
Mean pulmonary arterial pressure 
after CPB (mmHg)
20 1
Pulmonary wedge pressure prior to 
CPB (mmHg)
11 1
Pulmonary wedge pressure after 
CPB (mmHg)
12 1
Systemic vascular resistance prior to 
CPB (dyn/s per cm)
861 53
Systemic vascular resistance after 
CPB (dyn/s per cm)
727* 47
Pulmonary vascular resistance prior 
to CPB (dyn/s per cm)
115 10
Pulmonary vascular resistance after 
CPB (dyn/s per cm)
93 8
COPACtherm prior to CPB (l/minute) 6.2 0.4
COPACtherm after CPB (l/minute) 7.9* 0.3
COPiCCOtherm prior to CPB (l/minute) 6.2 0.3
COPiCCOtherm after CPB (l/minute) 7.6* 0.3
COPiCCOpulse after CPB (l/minute) 6.5 0.3
CPB, cardiopulmonary bypass. COPACtherm, pulmonary artery 
catheter thermodilution cardiac output; COPiCCOtherm, aortic 
transpulmonary thermodilution cardiac output; COPiCCOpulse, 
continuous arterial pulse contour analysis cardiac output.
*P < 0.05 compared with baseline.Available online http://ccforum.com/content/9/6/R729
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0.1 mg/kg midazolam, 0.03 mg/kg pancuronium and 0.6–1%
end-tidal isofluorane. All patients were ventilated with an oxy-
gen–air mixture (inspiratory oxygen fraction, 0.5) to maintain
an end-tidal partial pressure of carbon dioxide of 35–45
mmHg. The CPB technique was normothermic using intermit-
tent antegrade warm blood cardioplegia as described by
Calafiore and colleagues [14]. Transfusion management was
performed according to our standard operating procedure
[15]. The durations of anesthesia, surgery and aortic occlusion
and the number of coronary artery bypass grafts were
recorded.
Determination of cardiac output
Prior to CPB, the COPiCCOtherm and the COPACtherm were deter-
mined immediately after sternotomy under stable hemody-
namic conditions.
All volume substitution was stopped during the measure-
ments. The COPACtherm and the COPiCCOtherm were measured
by triple injection of 10 ml iced isotone sodium chloride solu-
tion into the central venous line of the PAC. The COPACtherm
and the COPiCCOtherm were calculated by commercially availa-
ble monitors (CCO module, Solar 8000; Marquette Hellige,
Freiburg, Germany; and PiCCO CCO monitor; Pulsion Medi-
cal AG). In case of a deviation >10% of a measurement, five
measurements were performed and the highest and lowest
were rejected. The COPiCCOpulse measurement was automati-
cally calibrated by the COPiCCOtherm  measurement. The
COPACtherm and the COPiCCOtherm measurements were carried
out simultaneously.
The measurement after CPB was carried out 15 minutes after
decanulation of the aorta. The prerequisite for this measure-
ment was an optimized preload and stable hemodynamic con-
dition with no damping of the arterial pressure line, which
could be achieved in all patients. At this time the COPiCCOpulse
was documented. Simultaneously, the COPiCCOtherm  and
COPACtherm were determined by thermodilution measurement
as already described.
Statistical analysis
All data are expressed as the mean and standard error of the
mean. Statistical analysis was performed by linear regression
analysis. The bias and limits of agreement (LOA) (two stand-
ard deviations) were assessed according to the method
described by Bland and Altman [16]. All numerical calcula-
tions were carried out with SPSS for WINDOWS (release
11.5.1, ©1989–2002; SPSS Inc, Chicago, IL, USA).
Results
Anesthesia and surgery were uncomplicated in all patients
analyzed during this study. Five patients had to be excluded
due to their impossibility to achieve a valid COPACtherm or COP-
iCCOtherm measurement. Therefore, 45 patients remained in the
study for analysis. Basic patient characteristics are presented
in Table 1. Hemodynamic data are presented in Table 2. The
heart rate, COPACtherm and COPiCCOtherm increased significantly
compared with the pre-CPB values. The systemic vascular
resistance decreased significantly compared with the baseline
measurement.
Prior to CPB, the regression analysis between the COPACtherm
and COPiCCOtherm measurements showed an excellent correla-
tion, with a correlation coefficient of 0.95 (P < 0.001). Bland–
Altman analysis showed a mean bias and LOA of 0.0 l/minute
and -1.4 to +1.4 l/minute. The regression analysis after CPB
also showed a good correlation between the COPACtherm and
the COPiCCOtherm, with a correlation coefficient of 0.82 (P <
0.001). The Bland–Altman analysis after CPB showed a mean
bias and a precision of 0.3 l/minute and -1.9 to +2.5 l/minute.
Comparison of COPiCCOpulse versus COPiCCOtherm and of COP-
iCCOpulse versus COPACtherm showed only a fair correlation after
CPB, with a correlation coefficient of 0.67 (P < 0.001) and
0.63 (P  < 0.001), respectively. Bland–Altman analysis
showed a mean bias and LOA of -1.1 l/minute and -1.9 to +4.1
l/minute versus -1.4 l/minute and -4.8 to +2.0 l/minute,
respectively.
Figure 1
Regression analysis of pulmonary artery catheter thermodilution cardiac  output (COPACtherm) versus aortic transpulmonary thermodilution car- diac output (COPiCCOtherm) prior to and after cardiopulmonary bypass  (CPB), and regression analysis of continuous arterial pulse contour  analysis cardiac output (COPiCCOpulse) versus COPiCCOtherm and versus  COPACtherm after CPB Regression analysis of pulmonary artery catheter thermodilution cardiac 
output (COPACtherm) versus aortic transpulmonary thermodilution car-
diac output (COPiCCOtherm) prior to and after cardiopulmonary bypass 
(CPB), and regression analysis of continuous arterial pulse contour 
analysis cardiac output (COPiCCOpulse) versus COPiCCOtherm and versus 
COPACtherm after CPB.Critical Care    Vol 9 No 6    Sander et al.
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Discussion
The main finding of this study is that the CO measured by
pulse contour analysis was considerably different compared
with the COPiCCOtherm and the COPACtherm. The COPiCCOtherm
and COPACtherm measurements correlated well before and after
CPB, indicating that CO measurement by pulse contour anal-
ysis needs to be recalibrated after CPB to achieve valid
results.
Pulse contour analysis CO has been shown previously to
serve as a valid and cost-effective device for CO determination
after calibration [17]. In our study we investigated the validity
of continuous CO measurement by pulse contour analysis
after CPB. The main advantage of COPiCCOpulse measurement
after CPB would be the fast determination of CO. As soon as
pulsatile flow is restored, the algorithm of the CO monitor
automatically starts determination of the CO by continuous
pulse contour analysis. Therefore, during a period when the
anesthetist's full attention is focused on vasoactive and vol-
ume therapy necessary for successful weaning from CPB, a
fast and continuous approach such as continuous pulse con-
tour analysis might be much more practical than time-consum-
ing intermittent thermodilution techniques for determination of
CO. However, these advantages would only apply if the
obtained data are valid.
The initial calibration of the COPiCCOpulse measurement was
performed by aortic transpulmonary CO determination prior to
CPB. We found an excellent correlation between the COPiC-
COtherm and the COPACtherm measurements. This correlation has
been described by previous investigators [12]. After CPB the
correlation remained good, but Bland-Altman analysis
revealed a trend for the COPiCCOtherm to slightly underestimate
the CO, with increased LOA compared with the measure-
ments prior to CPB. As we do not know the 'true' CO, it is
speculative which CO measurement estimates more precisely
the 'true' CO. An explanation for the greater scatter between
the two CO measurements after CPB compared with the
measurements prior to CPB might be an influx of cold blood.
This cold blood might be derived from compartments, which
might be hypoperfused during CPB and reperfused in the
period after CPB as suggested by previous investigators
[4,18]. Even though we performed normothermic CPB man-
agement, patients tended to display a slight decrease of their
Figure 2
Bland-Altman plot of pulmonary artery catheter thermodilution cardiac output (COPACtherm) versus aortic transpulmonary thermodilution cardiac out- put (COPiCCOtherm) prior to and after cardiopulmonary bypass (CPB), and Bland-Altman plot of continuous arterial pulse contour analysis cardiac out- put (COPiCCOpulse) versus COPiCCOtherm and versus COPACtherm after CPB Bland-Altman plot of pulmonary artery catheter thermodilution cardiac output (COPACtherm) versus aortic transpulmonary thermodilution cardiac out-
put (COPiCCOtherm) prior to and after cardiopulmonary bypass (CPB), and Bland-Altman plot of continuous arterial pulse contour analysis cardiac out-
put (COPiCCOpulse) versus COPiCCOtherm and versus COPACtherm after CPB. CO, cardiac output.Available online http://ccforum.com/content/9/6/R729
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body temperature, worsening the signal-to-noise ratio of the
thermal indicator used for determination of the CO by these
methods. Better results in this setting might be achieved using
an indicator independent from thermal signals. Given the
increased LOA of the COPiCCOtherm measurement, therefore,
the calibration of the pulse contour analysis with a thermal indi-
cator might be less than ideal in this period and should be
repeated early after surgery.
After CPB, the pulse contour CO showed marked differences
compared with the COPiCCOtherm  and COPACtherm  measure-
ments. The COPiCCOpulse measurement systematically under-
estimated the CO determined by the other two methods. This
has been described previously [4]. In our investigation the CO
and the heart rate increased significantly after CPB. We also
observed a significant decrease in systemic vascular resist-
ance after CPB. Differences between pulse contour CO and
thermodilution CO measurements in patients with significant
changes of the systemic vascular resistance [13] have already
been established in previous investigations. Further studies
are therefore needed, addressing also the performance of
newly developed pulse contour devices that do not include an
independent technique for calibration under difficult clinical
settings, such as after CPB.
The fact that we failed to determine the CO by a method inde-
pendent of thermal signals such as echocardiographic or lith-
ium dilution measurement of the CO to validate the thermal
dilution measurement [19,20] is a shortcoming of our study.
Bearing in mind, however, that we did find an excellent corre-
lation prior to CPB and a good correlation after CPB for the
two thermodilution measurements, we believe that the ther-
modilution methods represent a reliable estimation of the 'true'
CO in clinical practice. In case of severe hemodynamic insta-
bility after CPB, indicated by the COPiCCOpulse, COPiCCOtherm,
COPACtherm  or other clinical parameters, echocardiography
should be used to guide therapy as suggested previously [21].
It has been established formerly that pulse contour analysis
CO is a valid and cost-effective device for CO determination
after calibration. Another limitation is that the design of our
study does not allow for an ultimate demonstration of a causal
relationship between CPB and lack of agreement. However, a
number of studies show that pulse contour analysis is valid for
at least some hours if there are no severe changes in hemody-
namics. The mean time between sternotomy and the start of
CPB is about 60 minutes. We therefore think it is reasonable
to assume that CPB is mainly responsible for the inaccuracy
of the post-CPB pulse contour analysis observed in our study.
Conclusion
In conclusion, we observed an excellent correlation of COPiC-
COtherm and COPACtherm measurement prior to CPB. Our study
could not prove pulse contour analysis with a modified
Wesseling algorithm used in this study to be a method yielding
reliable results with excellent accuracy and limits of agreement
under difficult conditions after CPB in cardiac surgical
patients. Hence, due to the broad distribution and the under-
estimation of the CO after CPB, the use of the uncalibrated
continuous pulse contour cardiac output cannot be recom-
mended after weaning from CPB. A re-calibration in this set-
ting is essential.
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